Numbers displayed on the top left of each panel represent the animal identification number
(5.11) Adverse Reactions/Side Effects Most common adverse reactions (incidence 5%) in adults or pediatric patients aged 12 years and older are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss
Common hypoglycemia symptoms include dizziness, shakiness, and even confusion
28 , 29 Fewer than 20% of individuals undergoing lifestyle interventions achieve a weight reduction of 15%, and this is often followed by regaining one-third of the lost weight
Bruising after semaglutide shots is a common concern for patients using this glucagon-like peptide-1 (GLP-1) receptor agonist for type 2 diabetes or chronic weight management
Tirzepatide works through a fundamentally different mechanism, targeting two receptors instead of one, and the clinical data shows it consistently outperforms semaglutide for both weight loss and metabolic improvement